Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 30/04/20011 min de lecture
Abbott Laboratories’ Sarafloxacin for Poultry; Withdrawal of Approval of NADAs
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADAs) sponsored by Abbott Laboratories. The NADAs provide for use of sarafloxacin to treat poultry. In a final rule published elsewhere in this issue of the Federal Register , FDA is amending the animal drug regulations by removing the portions reflecting approval of these NADAs.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →